Parkinson's disease‐cognitive rating scale: A new cognitive scale specific for Parkinson's disease

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Movement Disorders

• Publication date

  2008-05-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/mds.22007PMID 18381647
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic and Statistical Manual of Mental Disorders

  2008cited by this paper
• Clinical diagnostic criteria for dementia associated with Parkinson's disease

  2007cited by this paper
• Is PD‐MCI a useful concept?

  2007cited by this paper
• Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

  2007cited by this paper
• Clinical phenotype of Parkinson disease dementia

  2006cited by this paper
• Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease.

  2006cited by this paper
• A magnetic resonance imaging study of patients with Parkinson’s disease with mild cognitive impairment and dementia using voxel-based morphometry

  2006cited by this paper
• The morphological basis of mental dysfunction in Parkinson's disease.

  2006influential reference
• Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease.

  2005cited by this paper
• The cerebellum's involvement in the judgment of spatial orientation: a functional magnetic resonance imaging study.

  2005cited by this paper
• Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium

  2005cited by this paper
• Dementia in Parkinson disease

  2005cited by this paper
• A systematic review of prevalence studies of dementia in Parkinson's disease

  2005cited by this paper
• Cerebral atrophy and its relation to cognitive impairment in Parkinson disease

  2005cited by this paper
• Cognitive profile of patients with newly diagnosed Parkinson disease

  2005cited by this paper
• Diagnosis and management of dementia with Lewy bodies

  2005cited by this paper
• Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.

  2004cited by this paper
• The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study.

  2004cited by this paper
• Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom

  2004cited by this paper
• Verbal fluency deficits in Parkinson's disease: A meta-analysis

  2004cited by this paper
• Visual perception in Parkinson disease dementia and dementia with Lewy bodies

  2004cited by this paper
• Switching from ergot to nonergot dopamine agonists in Parkinson's disease: A clinical series and five‐drug dose conversion table

  2004cited by this paper
• Assessment of cognition in Parkinson’s disease

  2003cited by this paper
• Performance on the dementia rating scale in Parkinson’s disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer’s disease

  2003cited by this paper
• Neuropsychological Profile of Patients with Parkinson’s Disease without Dementia

  2003cited by this paper
• What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration.

  2003cited by this paper
• Cognitive Impairments in Early Parkinson's Disease Are Accompanied by Reductions in Activity in Frontostriatal Neural Circuitry

  2003cited by this paper
• Fluctuations in attention

  2002cited by this paper
• Evaluation of the Hospital Anxiety and Depression Scale in Patients With Parkinson's Disease

  2002cited by this paper
• An event-related functional MRI study comparing interference effects in the Simon and Stroop tasks.

  2002cited by this paper
• Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study.

  2002cited by this paper
• Boston Naming Test

  2001cited by this paper
• Specific learning disabilities and difficulties in children and adolescents: The Wechsler intelligence scales

  2001cited by this paper
• Risk of dementia in Parkinson’s disease

  2001influential reference
• Mechanisms of cognitive set flexibility in Parkinson's disease.

  2001cited by this paper
• Lexical, semantic, and action verbal fluency in Parkinson's disease with and without dementia.

  1999influential reference
• Verbal memory in non-demented patients with idiopathic Parkinson's disease.

  1999cited by this paper
• A comparison of phonemic, semantic, and alternating word fluency in Parkinson's disease.

  1999cited by this paper
• CLOX: an executive clock drawing task

  1998cited by this paper
• Prospective comparative study of the evolution of probable Alzheimer's disease and Parkinson's disease dementia

  1998cited by this paper
• Neurobehavioral functioning in asymptomatic HIV-1 infected women

  1998cited by this paper
• Naming in dementia secondary to Parkinson's, Huntington's, and Alzheimer's diseases.

  1996cited by this paper
• Contributions to Neuropsychological Assessment

  1995cited by this paper
• Individual-patient monitoring in clinical practice: are available health status surveys adequate?

  1995cited by this paper
• Is semantic memory consistently impaired early in the course of Alzheimer's disease? Neuroanatomical and diagnostic implications

  1995cited by this paper
• Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkinson's disease.

  1995influential reference
• Neuropsychological characteristics of preclinical dementia in Parkinson's disease

  1995cited by this paper
• The Mattis Dementia Rating Scale

  1994cited by this paper
• Implicit and explicit memory in patients with Parkinson's disease with and without dementia.

  1994cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• Fronto-striatal cognitive deficits at different stages of Parkinson's disease.

  1992cited by this paper
• Cholinergic deficiency and frontal dysfunction in Parkinson's disease

  1990cited by this paper
• 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa.

  1988cited by this paper
• Cerebral blood flow in dementia

  1986cited by this paper
• A New Clinical Scale for the Staging of Dementia

  1982cited by this paper
• Psychometric theory (2nd ed.).

  1979cited by this paper
• The measurement of observer agreement for categorical data.

  1977cited by this paper
• Cerebral blood flow in dementia.

  1975cited by this paper
• The prevention of acute gastric ulcer in the rat by alpha-methyldopa.

  1967cited by this paper
• Parkinsonism

  1967cited by this paper
• The relative value of various somatic therapies in schizophrenia.

  1960cited by this paper
• THE PSYCHOLOGICAL CORPORATION.

  1923cited by this paper

• Cortical activation and functional connectivity between healthy elderly and Parkinson’s disease patients and between cognitive subgroups of Parkinson’s patients: a multichannel functional near-infrared spectroscopy study

  2026cites this paper
• Effects of immersive virtual reality and adaptive cognitive training on cognition and function in parkinson’s disease mild cognitive impairment: a randomized clinical trial

  2026cites this paper
• Imaging biomarkers of cortical neurodegeneration underlying cognitive impairment in Parkinson’s disease

  2025cites this paper
• Associations between frailty and cognitive impairment in Parkinson´s disease: a cross-sectional study

  2025influential citation
• Approaches for treating neuropsychiatric symptoms in Parkinson’s disease: a narrative review

  2025cites this paper
• Speech and language outcome measures in clinical trials of Alzheimer’s and Parkinson’s diseases

  2025cites this paper
• Early Language Impairment as an Integral Part of the Cognitive Phenotype in Huntington's Disease

  2025cites this paper
• Diagnostics and Ecological Validity of the Italian Version of the Parkinson’s Disease Cognitive Rating Scale

  2025cites this paper
• CSF Biomarker‐Based Cognitive Trajectories in Parkinson's Disease‐Subjective Cognitive Decline

  2025cites this paper
• Exploring the Facilitators and Barriers of Adherence to Mediterranean-Ketogenic Dietary Interventions in Parkinson’s Disease: A Qualitative Study

  2025cites this paper
• Grey matter loss across deteriorating cognitive stages in Parkinson's disease.

  2025influential citation
• Device-aided therapies (DATs) in Parkinson’s disease (PD). The DATs-PD GETM Spanish Registry Protocol Study

  2025cites this paper
• The impact of mild-to-moderate cortical cognitive deficits on post-operative outcomes in deep brain stimulation for Parkinson’s disease: Considerations for patient selection

  2025cites this paper
• Cognitive Impairment in Patients with Parkinson’s Disease

  2025cites this paper
• A Randomized Safety and Feasibility Crossover Trial of two Mediterranean-Ketogenic Interventions in Individuals with Parkinson's Disease

  2025cites this paper
• Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline

  2025cites this paper
• Cortical volumetry and longitudinal cognitive changes in Parkinson’s disease: insights from the COPPADIS cohort

  2025cites this paper
• Neural and biomarker correlates of the Parkinson's Disease–Cognitive Rating Scale in Huntington's disease

  2025cites this paper
• Data-driven characterization of distinct cognitive subtypes in Parkinson’s disease dementia

  2025cites this paper
• How to advance the pharmacological management of cognitive impairment in Parkinson's disease.

  2025cites this paper
• A Qualitative Approach to Extract Diagnostic Patterns of Cognitive Impairment in Parkinson’s Disease

  2025cites this paper
• Disrupted visual-to-semantic dynamics promote visual hallucinations in Parkinson’s disease

  2025cites this paper
• Consolidation deficits in episodic memory define distinct clinical and neurodegenerative profiles in Huntington’s disease

  2025cites this paper
• Effects of task-specific training on motor activity, cognitive function, and quality of life among individuals with Parkinson’s disease: a quasi-experimental pilot study

  2025cites this paper
• Cognitive Phenotyping of Parkinson's Disease Patients Via Digital Analysis of Spoken Word Properties

  2025cites this paper
• Retro-Walking and Cholinergic Network Correlates in Parkinson’s Disease

  2025cites this paper
• Influence of the level of education on cognitive function in Parkinson's disease.

  2025cites this paper
• A randomized clinical trial to evaluate the efficacy of cognitive rehabilitation and music therapy in mild cognitive impairment in Huntington’s disease

  2025cites this paper
• Ambroxol as a Treatment for Parkinson Disease Dementia: A Randomized Clinical Trial.

  2025cites this paper
• Facial emotion recognition deficits are associated with hypomimia and related brain correlates in Parkinson’s disease

  2024cites this paper
• Levodopa‐Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5‐Year Follow‐Up Study

  2024cites this paper
• Total burden of cerebral small vessel disease predict subjective cognitive decline in patients with Parkinson’s disease

  2024influential citation
• Comparing the effects of augmented virtual reality treadmill training versus conventional treadmill training in patients with stage II-III Parkinson’s disease: the VIRTREAD-PD randomized controlled trial protocol

  2024cites this paper
• Relationship of foot pain with the increased risk of falls in patients with Parkinson’s disease

  2024influential citation
• Cognitive phenotyping of GBA1-Parkinson's disease: A study on deep brain stimulation outcomes.

  2024cites this paper
• Mapping brain morphology to cognitive deficits: a study on PD-CRS scores in Parkinson’s disease with mild cognitive impairment

  2024influential citation
• p.L1795F LRRK2 variant is a common cause of Parkinson’s disease in Central Europe

  2024cites this paper
• The Parkinson's Disease Composite of Executive Functioning

  2024cites this paper
• Impact of Stimulation Frequency on Verbal Fluency Following Bilateral Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease.

  2024cites this paper
• Evaluating the Effects of Bimanual Activities with and Without Motivational Strategies on Participation and Upper Extremity Function in Subjects with Parkinson's Disease: Study Protocol for a Randomized Controlled Trial

  2024cites this paper
• Neuropsychological Assessment for Early Detection and Diagnosis of Dementia: Current Knowledge and New Insights

  2024cites this paper
• Cortical hypometabolism in Parkinson’s disease is linked to cholinergic basal forebrain atrophy

  2024cites this paper
• Cognitive phenotype and neurodegeneration associated with Tau in Huntington's disease

  2024cites this paper
• A systematic review of the associations between sedentary behavior, physical inactivity, and non-motor symptoms of Parkinson’s disease

  2024cites this paper
• Parkinson’s disease CA2-CA3 hippocampal atrophy is accompanied by increased cholinergic innervation in patients with normal cognition but not in patients with mild cognitive impairment

  2024cites this paper
• Validation of the Italian version of the Parkinson’s Disease- Cognitive Functional Rating Scale

  2024cites this paper
• Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4‐Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological Biomarkers

  2024cites this paper
• Psychometrics and diagnostics of the Italian version of the Alternate Verbal Fluency Battery (AVFB) in non-demented Parkinson’s disease patients

  2024cites this paper
• The discriminative linguistic profiles of progressive supranuclear palsy and Parkinson's disease.

  2024cites this paper
• Outcome Measures for Disease-Modifying Trials in Parkinson’s Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative

  2023cites this paper
• Cognitive impairment and dementia in young onset Parkinson’s disease

  2023cites this paper
• Role of multimodal advanced biomarkers as potential predictors of cognitive and psychiatric aspects of Parkinson's disease

  2023influential citation
• Cognitive Impairment in Neurodegenerative Movement Disorders

  2023cites this paper
• A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease.

  2023cites this paper
• Brainstem neuromelanin and iron MRI reveals a precise signature for idiopathic and LRRK2 Parkinson’s disease

  2023cites this paper
• Risk of Cognitive Impairment in Patients With Parkinson’s Disease With Visual Hallucinations and Subjective Cognitive Complaints

  2023cites this paper
• First Longitudinal Study Using Binaural Beats on Parkinson Disease

  2023cites this paper
• Structural and metabolic brain correlates of arithmetic word‐problem solving in Huntington's disease

  2023cites this paper
• Parkinson's Disease‐Cognitive Rating Scale (PD‐CRS): Normative Data and Mild Cognitive Impairment Assessment in Brazil

  2023cites this paper
• Beyond shallow feelings of complex affect: Non-motor correlates of subjective emotional experience in Parkinson’s disease

  2023cites this paper
• Global assessment, cognitive profile, and characteristics of mild cognitive impairment in Parkinson's disease

  2023cites this paper
• Measuring cognitive impairment and monitoring cognitive decline in Huntington’s disease: a comparison of assessment instruments

  2023cites this paper
• The role of attentional control over interference in minor hallucinations in Parkinson's disease.

  2022cites this paper
• Astrogliosis in aging and Parkinson’s disease dementia: a new clinical study with 11C-BU99008 PET

  2022cites this paper
• Artificial Intelligent Olfactory System for the Diagnosis of Parkinson’s Disease

  2022cites this paper
• Promoting independence in Lewy body dementia through exercise: the PRIDE study

  2022influential citation
• The Italian version of the alternative form of Parkinson’s Disease-Cognitive Rating Scale (PD-CRS/AF): normative values from 260 Italian healthy subjects

  2022influential citation
• Prevalence of Fabry Disease among Patients with Parkinson's Disease

  2022cites this paper
• Predicting Impulse Control Disorders in Parkinson Disease through Incentive Biomarkers

  2022cites this paper
• Research on depression in Parkinson disease: A bibliometric and visual analysis of studies published during 2012–2021

  2022cites this paper
• Cognitive Syndromes Associated With Movement Disorders

  2022cites this paper
• Which Test Is the Best to Assess Visuo-Cognitive Impairment in Patients with Parkinson’s Disease with Mild Cognitive Impairment and Dementia? A Systematic Review and Meta-Analysis

  2022cites this paper
• Multi-Disease Validation of the RUDAS for Cognitive Screening in Alzheimer’s Disease, Parkinson’s Disease, and Multiple Sclerosis

  2022cites this paper
• Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson's disease.

  2022cites this paper
• Clinical and structural brain correlates of hypomimia in early‐stage Parkinson's disease

  2022influential citation
• Identification of cholinergic centro-cingulate topography as main contributor to cognitive functioning in Parkinson’s disease: Results from a data-driven approach

  2022cites this paper
• Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study

  2022influential citation
• Theta oscillations and minor hallucinations in Parkinson’s disease reveal decrease in frontal lobe functions and later cognitive decline

  2022influential citation
• Caring for patients with cognitive dysfunction, fluctuations and dementia caused by Parkinson's disease.

  2022cites this paper
• Personalized Assessment of Insomnia and Sleep Quality in Patients with Parkinson’s Disease

  2022cites this paper
• Optimization of cognitive assessment in Parkinsonisms by applying artificial intelligence to a comprehensive screening test

  2022cites this paper
• Psychometric properties and construct validity of the Parkinson’s Disease-Cognitive Rating Scale (PD-CRS) in Colombia

  2022influential citation
• Falls Predict Acute Hospitalization in Parkinson’s Disease

  2021cites this paper
• Robot-induced hallucinations in Parkinson’s disease depend on altered sensorimotor processing in fronto-temporal network

  2021cites this paper
• Clock-Drawing Tasks as Predictive Measurements for Disease Classification Among Patients With Parkinson’s Disease and Essential Tremor

  2021influential citation
• Parkinson’s Disease Motor Subtypes Change with the Progression of the Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up

  2021cites this paper
• Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease

  2021cites this paper
• Defining Atypical Anxiety in Parkinson's Disease

  2021cites this paper
• Challenges in Predicting Cognitive Decline in Dementia with Lewy Bodies

  2021cites this paper
• Predictors of clinically significant quality of life impairment in Parkinson’s disease

  2021cites this paper
• Cognitive and Behavioral Inhibition Deficits in Parkinson’s Disease: The Hayling Test as a Reliable Marker

  2021cites this paper
• The Parkinson’s Disease-Cognitive Rating Scale: Greek Normative Data, Clinical Utility and Cultural Considerations

  2021cites this paper
• Hypomimia in Parkinson's Disease: What Is It Telling Us?

  2021cites this paper
• Clinical Trials for Depression , Anxiety , Fatigue , and Apathy in Parkinson’s Disease

  2021cites this paper
• Plasma acyl-carnitines, bilirubin, tyramine and tetrahydro-21-deoxycortisol in Parkinson's disease and essential tremor. A case control biomarker study.

  2021cites this paper
• Constipation Predicts Cognitive Decline in Parkinson’s Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group

  2021cites this paper
• Clinical Trials In Parkinson's Disease

  2021cites this paper
• Arithmetic Word-Problem Solving as Cognitive Marker of Progression in Pre-Manifest and Manifest Huntington’s Disease

  2021cites this paper
• Premotor Parkinson's disease: Overview of clinical symptoms and current diagnostic methods.

  2021cites this paper
• Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐up

  2021cites this paper